AstraZeneca, MSD sue MSN and Sandoz over Calquence generics

08-02-2022

Alex Baldwin

AstraZeneca, MSD sue MSN and Sandoz over Calquence generics

askarim / Shutterstock.com

AstraZeneca and Merck, Sharp & Dohme (MSD) have filed a pair of lawsuits against MSN and Sandoz, claiming their planned generic versions of its leukaemia treatment Calquence (acalabrutinib) infringe six patents.


AstraZeneca, MSD, MSN, Sandoz, Calquence, US District Court for the District of Delaware, generics

LSIPR